Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Journal of Cardiovascular Development and Disease|December 22, 2022
Factor XI/XIa Inhibition: The Arsenal in Development for a New Therapeutic Target in Cardio- and Cerebrovascular DiseaseJuan J Badimon, Gines Escolar, M Urooj ZafarThrombosis and Haemostasis|October 2, 2010
Prostanoid and TP-receptors in atherothrombosis: is there a role for their antagonism?Chiara Giannarelli, M Urooj Zafar, Juan J BadimonPlatelets|October 23, 2009
Platelet reactivity and nonresponse to dual antiplatelet therapy: a reviewPeter M Vila, M Urooj Zafar, Juan J BadimonJournal of Interventional Cardiology|June 6, 2009
Crushed clopidogrel administered via nasogastric tube has faster and greater absorption than oral whole tabletsM Urooj Zafar, Michael E Farkouh, Valentin Fuster, et al.Methods in Molecular Biology (Clifton, N.J.)|July 11, 2018
Badimon Perfusion Chamber: An Ex Vivo Model of ThrombosisM Urooj Zafar, Carlos G Santos-Gallego, Lina Badimon, et al.Expert Opinion on Drug Metabolism & Toxicology|March 2, 2019
Metabolism of the failing heart and the impact of SGLT2 inhibitorsAlvaro Garcia-Ropero, Carlos G Santos-Gallego, M Urooj Zafar, et al.Cardiovascular Drugs and Therapy|August 3, 2022
SGLT2-Inhibitors on HFpEF Patients. Role of Ejection FractionJuan Antonio Requena-Ibanez, Carlos G Santos-Gallego, M Urooj Zafar, et al.Clinics in Laboratory Medicine|August 30, 2006
Measures of thrombosis and fibrinolysisBrian G Choi, Gemma Vilahur, Borja Ibanez, et al.Journal of Cardiovascular Pharmacology|April 9, 2004
Tissue factor coagulation pathway: a new therapeutic target in atherothrombosisJuan F Viles-Gonzalez, Sunil X Anand, M Urooj Zafar, et al.Atherosclerosis|October 10, 2017
Dronedarone exerts anticoagulant and antiplatelet effects independently of its antiarrhythmic actionsM Urooj Zafar, Carlos G Santos-Gallego, Donald A Smith, et al.Pageof 4